Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · May 07, 2022

Use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure Due to COVID-19

Journal of Intensive Care Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Intensive Care Medicine
Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19
J Intensive Care Med 2022 Apr 04;[EPub Ahead of Print], L Matthews, L Baker, M Ferrari, W Sanchez, J Pappachan, MP Grocott, A Dushianthan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading